Q&A: AbbVie VP Lin On Filling Humira's Big Shoes In Immunology

AbbVie's Shao-Lee Lin talks about drug candidates that the company hopes will extend its legacy in immunology, which is built on the foundation of the world's top-selling biopharma product Humira.